Sherwin-Williams director granted 558-share equity award

Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock on February 17, 2026.

Rhea-AI Filing Summary

Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock on February 17, 2026. The filing classifies this as an acquisition granted at a price of $0.00 per share under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan.

The award is in the form of restricted stock units, each representing the right to receive one share of Common Stock. These RSUs vest annually in three substantially equal installments starting on February 16, 2027. After this grant, Powell beneficially owns 3,587 shares in total, consisting of 1,100 RSUs and 2,487 shares of Common Stock held directly.

Insider Trade Summary

Grant/Award: 558 shares

Grant/Award 1 txn

Insider Powell Aaron

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	558	$0.00	$0.00

Holdings After Transaction: Common Stock — 3,587 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.
2. F2. These securities consist of 1,100 RSUs and 2,487 shares of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sherwin-Williams (SHW) director Aaron Powell report in this Form 4?

Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock. The award is a grant classified as an acquisition, issued at $0.00 per share under the company’s 2025 Equity and Incentive Compensation Plan.

Was Aaron Powell’s Sherwin-Williams (SHW) Form 4 transaction a purchase or a grant?

The Form 4 for Aaron Powell reports a grant, not an open-market purchase. It is coded as an acquisition resulting from a grant or award, delivered at $0.00 per share as part of Sherwin-Williams’ 2025 Equity and Incentive Compensation Plan.

How many Sherwin-Williams (SHW) shares did Aaron Powell acquire in this filing?

Aaron Powell acquired an award tied to 558 shares of Sherwin-Williams Common Stock. This equity grant was recorded at $0.00 per share and increased his total beneficial ownership, combining both restricted stock units and directly held shares after the transaction.

How do Aaron Powell’s Sherwin-Williams (SHW) RSUs vest from this grant?

The restricted stock units granted to Aaron Powell vest in three substantially equal annual installments. Vesting begins on February 16, 2027, meaning the award will phase in over three years rather than becoming fully vested immediately at the grant date.

What is Aaron Powell’s total beneficial ownership in Sherwin-Williams (SHW) after this Form 4?

After this Form 4 transaction, Aaron Powell beneficially owns 3,587 Sherwin-Williams-related shares. This total consists of 1,100 restricted stock units and 2,487 shares of Common Stock, all reported as directly owned following the equity grant.

Under which plan was Aaron Powell’s Sherwin-Williams (SHW) equity grant made?

Aaron Powell’s equity grant was issued under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. The award is structured as restricted stock units, each representing the right to receive one share of Sherwin-Williams Common Stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 06:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Powell Aaron

(Last) (First) (Middle)

1 SHERWIN WAY

(Street)

CLEVELAND OH 44113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		558(1)	A	$0	3,587(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.

2. These securities consist of 1,100 RSUs and 2,487 shares of Common Stock.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.